miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates - Wikidata - wikimedia - TriplyDB

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

http://www.wikidata.org/entity/Q24647285

about

Inhibition of microRNA function by antimiR oligonucleotides Efficient inhibition of miR-155 function in vivo by peptide nucleic acids Cloning, characterization and expression analysis of porcine microRNAs Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis Non-coding RNAs as theranostics in human cancers Emerging role of microRNAs in lipid metabolism Antisense oligonucleotides: treating neurodegeneration at the level of RNA miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Recent Developments in Peptide-Based Nucleic Acid Delivery Silencing Viral MicroRNA as a Novel Antiviral Therapy?Targeting viral infection by microRNA inhibition MicroRNAs in atherosclerosis and lipoprotein metabolism Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs Silencing disease genes in the laboratory and the clinic Sequence-non-specific effects of RNA interference triggers and microRNA regulators.Expression profiles of miRNA-122 and its target CAT1 in minipigs (Sus scrofa) fed a high-cholesterol diet.Development of microRNA therapeutics is coming of age.Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model Comparative genome-wide analysis of small RNAs of major Gram-positive pathogens: from identification to application Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection.Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier.MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity Contributions of stacking, preorganization, and hydrogen bonding to the thermodynamic stability of duplexes between RNA and 2'-O-methyl RNA with locked nucleic acids.Silencing microRNA by interfering nanoparticles in mice.A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference Spatiotemporal dynamics of microRNA during epithelial collective cell migration.Targeting microRNA-122 to Treat Hepatitis C Virus Infection.Functional Studies of microRNAs in Neural Stem Cells: Problems and Perspectives MiRNA inhibition in tissue engineering and regenerative medicine.Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.DNA and RNA derivatives to optimize distribution and delivery Approaches to manipulating microRNAs in neurogenesis.Recombinant adenoviral microRNA-206 induces myogenesis in C2C12 cells Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells.Potent inhibition of microRNA in vivo without degradation Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

P2860

Q21198757-22949E2D-778B-4175-9F6E-9E27CB758A63 Q24603017-41951E07-6E0C-4F3D-9CE8-5D0C7C0124D6 Q24651039-745E3B1E-4080-49CC-9F77-EEB697895272 Q26739857-886CB285-22D2-4AFC-8206-08D5990DDA1D Q26746958-0D37C51C-8693-475F-80F0-6182C3C15D39 Q26851250-80453F2E-6BDF-48C2-94EE-616F166000C3 Q26852591-9C359616-5E5F-495F-9BF9-6BE8722B2A3B Q27007056-06DDC6B2-3F4C-4D6A-828A-07E7DA767AB5 Q27023295-885C44D0-C2A6-4470-ABDF-975AD91A42D4 Q27487857-72E27B45-F7E5-46B9-A3B7-1C847C995671 Q27488437-2D116FF3-93B9-41CF-B872-45C71A35C5A6 Q27491314-3092728A-2BF4-49A2-BF26-719983F5B7AA Q27692124-0BCB8378-A6FF-4151-95D6-70826DB208F1 Q28914781-60DF99BB-7D54-42E3-94E3-2F79772B469B Q29039090-978E7264-56FF-4DBE-AEF9-2DD3A855B2F2 Q33566425-51028DBC-8617-465A-AF6F-08A53816A92C Q33791166-A5979565-8143-4458-BDEF-D1723355EC02 Q33991443-49530156-90C6-4ED3-9176-B65C0C9C4BA2 Q33991823-8692F048-D046-4492-B5C6-40A3E185B7C7 Q34117470-C71F30F1-6A13-4E8B-8722-7B339F2D17AE Q34160197-E7374675-F7C3-4134-8E77-DF319CC5DD59 Q34192857-C2D0DBC2-B0AF-43DD-9525-5FABB53B5E5E Q34236236-FB35D0A6-0B4B-491B-8535-633E0C342DA4 Q34367048-6AF57C98-23FD-465D-9D54-29B8F392187F Q34478419-4AA5AEC2-3710-421A-AC50-7471C70ABEB0 Q34543881-B0C02FAE-CF85-48A7-ADB9-839088947B36 Q34723841-5B3ADD09-1E06-42C3-984B-A2D867F67C4C Q34919422-A1579C0C-8108-4343-B708-E57139555B6F Q35032629-632045B1-D791-48AF-935F-5026FF8C5E82 Q35261089-EE643F9B-B897-4744-9076-FCAE3B728F48 Q35740397-CA0AD5EE-BEDA-4ED9-8EA6-A6F8EF91C4BD Q35799937-0E66E018-6253-4F1A-B86B-9B71D8841CC6 Q35823712-676614E2-7941-420D-B55F-28A04EF00679 Q35858691-B1A4FBD3-B297-42A7-9563-7ADDDBBD1803 Q36540632-F59BB847-0FC4-4636-A4C0-630845BCDE4C Q36771442-075BF185-AF06-4E56-B7EF-4287D61AAAEF Q36920080-F0B4CD49-BAD0-49F9-9BAC-06317E0EB280 Q37041859-62AE43BA-376D-4536-95B4-82BE757D5250 Q37134134-2EFF9CE5-E958-4AAA-857C-0A8168F48CFB Q37189998-A6DF3706-2295-4979-8B71-9CCC197D992F

P2860

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

http://www.wikidata.org/entity/Q24647285

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@ast

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@en

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@nl

type

label

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@ast

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@en

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@nl

prefLabel

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@ast

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@en

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@nl

P1433

Q24647285-C9241EE2-8398-4D0E-ACCA-88CF25DCF593

P1476

Q24647285-F0C31257-3911-48ED-8140-2274E181C49A

P2093

Q24647285-59E1DD62-9F21-4E4A-B96F-C81CAE61B06C

Q24647285-945A8EB0-DAB8-43FA-B019-823A2E0BF2F8

P2860

Q24647285-05542DEF-0D06-4FA9-84F0-A8276E52F9B3

Q24647285-094E013F-0A5C-4968-9F05-66CC0F7E9666

Q24647285-0D580649-1780-4916-B3C6-E95E8F8D8655

Q24647285-1BEAB5F9-AF6A-4DEE-8840-11764DAEED54

Q24647285-1D33B42D-A6A9-495C-AEC2-3D4CF856723A

Q24647285-2824148B-C526-4002-B9AF-62467ED58BE6

Q24647285-29DB1DF2-145C-4D6E-9C50-1C71B3EDA205

Q24647285-348FD7C6-F0C3-4B5B-8B80-F744FEEE9680

Q24647285-4B6536E3-7986-40F8-829D-7B7E8C1C9DE9

Q24647285-53D67463-7650-474E-B1D2-0F9B519C2B5C

P304

Q24647285-10857A57-167D-45C5-A162-8DEE210CFF55

P31

Q24647285-30759DE8-FF26-4FA7-8A3F-06DB24095F99

P3181

Q24647285-61FE1D97-B2F9-49CA-B851-C0B580AE0EDB

P356

Q24647285-B42F0499-FE4B-4A31-8146-526076CCBBC6

P407

Q24647285-CE8E68B0-7677-435B-95CB-86D6F1A5DBD4

P433

Q24647285-FC6D8217-B72B-4E79-9BE1-4BA0E7B5DA0B

P478

Q24647285-7311CB06-8F43-4B36-8E0E-2778C28AD73B

P577

Q24647285-3D41AF0F-1E4B-402E-A0B5-C05462525200

P5875

Q24647285-1D19F29D-E368-460A-B505-352F2042DDD9

P698

Q24647285-D850CE7B-5368-409D-9B1C-53C9E4551DD3

P932

Q24647285-6113A131-1E80-45D1-AA55-E0186D057C4B

P3181

P356

P1433

P1476

miR-122 targeting with LNA/2'- ...... A), and PNA-peptide conjugates

@en

P2093

Martin M Fabani

http://www.w3.org/2001/XMLSchema#string

Michael J Gait

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development

miR-15 and miR-16 induce apoptosis by targeting BCL2

Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing

miRBase: microRNA sequences, targets and gene nomenclature

Improved targeting of miRNA with antisense oligonucleotides

MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

MicroRNA-155 is induced during the macrophage inflammatory response

Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

P304

336-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1549343

http://www.w3.org/2001/XMLSchema#string

P356

10.1261/RNA.844108

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5775749

http://www.w3.org/2001/XMLSchema#string

P698

18073344

http://www.w3.org/2001/XMLSchema#string

P932

2212241

http://www.w3.org/2001/XMLSchema#string